Eiichi Katsumoto
- Psychiatry and Mental health top 10%
- Bipolar Disorder and Treatment 13
- Electroconvulsive Therapy Studies 11
- Schizophrenia research and treatment 6
- Epilepsy research and treatment 4
-
- Neuroscience and Neuropharmacology Research 5
-
- Sleep and related disorders 3
-
- Neurological Disease Mechanisms and Treatments 2
-
- Pharmacological Effects and Toxicity Studies 2
Eiichi Katsumoto
25 papers receiving 157 citations
Peers
Comparison fields: 5 of 44
- Psychiatry and Mental health 118
- Biological Psychiatry 6
- Speech and Hearing 14
- Cellular and Molecular Neuroscience 19
- Experimental and Cognitive Psychology 12
Countries citing papers authored by Eiichi Katsumoto
This map shows the geographic impact of Eiichi Katsumoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiichi Katsumoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiichi Katsumoto more than expected).
Fields of papers citing papers by Eiichi Katsumoto
This network shows the impact of papers produced by Eiichi Katsumoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiichi Katsumoto. The network helps show where Eiichi Katsumoto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eiichi Katsumoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2023 | 6 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 2 | |
| 7 | 2021 | 5 | |
| 8 | 2021 | 10 | |
| 9 | 2021 | 7 | |
| 10 | 2021 | 4 | |
| 11 | 2020 | 16 | |
| 12 | 2020 | 15 | |
| 13 | 2020 | 20 | |
| 14 | 2020 | 10 | |
| 15 | 1998 | 13 | |
| 16 | 1997 | 9 | |
| 17 | 1996 | 1 | |
| 18 | 1995 | 1 | |
| 19 | 1993 | 0 | |
| 20 | 1992 | 1 |
About Eiichi Katsumoto
Eiichi Katsumoto is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Speech and Hearing, having authored 26 papers that have together received 159 indexed citations. Recurring topics across this work include Bipolar Disorder and Treatment (13 papers), Electroconvulsive Therapy Studies (11 papers), Schizophrenia research and treatment (6 papers), Neuroscience and Neuropharmacology Research (5 papers), Epilepsy research and treatment (4 papers), Sleep and related disorders (3 papers), Neurological Disease Mechanisms and Treatments (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). The work is most often cited by research in Psychiatry and Mental health (118 citations), Biological Psychiatry (6 citations) and Speech and Hearing (14 citations). Eiichi Katsumoto has collaborated with scholars based in Japan and United States. Frequent co-authors include Takashi Tsuboi, Seiji Hongo, Atsuo Nakagawa, Masaki Kato, Hitoshi Ueda, Reiji Yoshimura, Koichiro Watanabe, Naoto Adachi, Sakae Yamagami and Norio Yasui‐Furukori. Their work appears in journals such as Frontiers in Psychiatry, Epilepsia, European Neuropsychopharmacology, Journal of Psychiatric Research and International Journal of Environmental Research and Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.